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.2012.10.Abstract Background: Preanesthetic medication in pediatrics is very helpful in relieving anxiety,
fear, and psychological trauma due to maternal deprivation. Many drugs used in different routes
aiming to alleviate stress and prevent psychological trauma. Of these drugs midazolam and keta-
mine are commonly used. We aimed in this work to compare both of them with dexmedetomidine
which is a 2-agonist when used intranasally in children undergoing bone marrow biopsy and aspi-
rate in sedation and premedication.
Methods: 96 children aged 2–8 years with ASA physical status II scheduled for bone marrow
biopsy and aspirate were divided into three groups 32 child in each one: (M group) who were pre-
medicated with intranasal midazolam 0.2 mg/kg, (D group) who were premedicated with intranasal
dexmedetomidine 1 lg/kg, and (K group) who were premedicated with intranasal ketamine
5 mg/kg. The degree of sedation was assessed every 5 min for 30 min by using a 4 point sedation
scale. Also, child–parent separation was assessed and graded according to a 4 point scale at 30 min.
Results: We found that dexmedetomidine group achieved a faster sedation score less than 3 at the
point of 10 min, then all groups achieved a comparable sedation score till point of 25 min, both dex-
medetomidine and midazolam groups had better sedation score than ketamine group at 30 min.
Children achieved child–parents separation score grade 1 was signiﬁcantly higher in dexmedetom-
idine group than midazolam and ketamine groups.partment of Anesthesiology,
iversity, Asyut 71516, Egypt.
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132 M.G. Mostafa, K.M. MorsyConclusions: Midazolam, ketamine and dexmedetomidine produced adequate sedation with little
side effects. So, we prefer to use midazolam due its efﬁcacy and safety as well as availability and
its low price in comparison to ketamine and dexmedetomidine.
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Anxiety and the psychological trauma due to maternal depri-
vation are major challenges in pediatric anesthesia. Preanes-
thetic medication in children should aim at relieving this
anxiety and psychological trauma parents and also to facilitate
the induction of anesthesia without prolonging the recovery
[1]. Several drugs have been tried to ﬁnd the best sedative agent
and the best route of administration of these drugs in children.
So, a premedicant drug must have an acceptable, non-trau-
matic route of administration in order not add extra stress to
the child. Currently the most commonly drugs are midazolam,
ketamine, transmucosal fentanyl and/or meperidine. Many
studies have shown that intranasal route is an effective way
to administer premedication and sedation to children [2,3]. It
is a relatively easy non-invasive route with high bioavilability
and rapid onset of action comparable to that of IV administra-
tion because of the rich blood supply of the airway mucosa and
bypassing the ﬁrst pass hepatic metabolism. Also, this route is
not painful and does not require trained personnel [4–6].
Midazolam is a water-soluble benzodiazepine known to have
a rapid onset and short duration of action, as well as properties
of amnesia and anxiolysis. Administered intranasally, midazo-
lam is an effective option for conscious sedation [7,8]. Keta-
mine is a dissociative anesthetic that creates a trance-like
state with properties of sedation, amnesia, analgesia, and cat-
alepsy [9]. Dexmedetomidine is a newer alpha 2-agonist with a
more selective action on the alpha 2-adrenoceptor and a short-
er half-life [10,11] its bioavailability is (72.6–92.1%) when
administered via the nasal mucosa.
The aim of this study is to compare the sedative effects of
midazolam, ketamine and dexemedetomidine when adminis-
tered intranasally as preanesthetic medication for children
undergoing sternal puncture for bone marrow biopsy and aspi-
rate from pubic bone.
2. Materials and methods
This study was carried out in the Department of Pediatric
oncology in association with the Department of Anesthesiology
after obtaining consent from guardians and ofﬁcial approval of
the ethical committee. Exclusion criteria included known al-
lergy to the studied drugs, organ dysfunction, cardiac dysr-
rhythmia and/or congenital heart disease, psychotropic
medication use and mental retardation as well as any nasal dis-
order that may interfere with nasal administration of drugs as
recurrent nasal bleeding or nasal masses. Also, the children
who spit, sniffed or refused intranasal administration of medi-
cation were excluded. 96 children aged 2–8 years were selected
for this randomized double blind controlled clinical trial in
accordance with American Society of Anesthesiologists
(ASA) physical status II scheduled for bone marrow biopsy
and aspirate were divided into three groups: intranasalmidazolam group (M group) (n= 32) 0.2 mg/kg (Dormicum,
5 mg/mL; F. Hoffman La Roche Ltd., Basel, Switzerland),
intranasal dexmedetomidine group (D group) (n= 32) (1 lg/
kg) (Precedex, 200 lg per 2 mL; Abbott, USA) and intranasal
ketamine group (K group) (n= 32) (5 mg/kg) (HIKMA Phar-
maceuticals, Amman-Jordan). All study drugs were prepared
by second researcher and packed in identical black plastic con-
tainers labeled with numbers that code its content. Observers
and attending anesthesiologists were blinded to the given drug.
Medications were administered 30 min prior to induction, in
the pre-anesthesia area, with the parent(s) attendance. Intrana-
sal drug was dripped into both nostrils using a 2-mL syringe
with the child in the recumbent position. Inhalation induction
was initiated by face mask with a mixture of sevoﬂurane 8%
with O2 100%. After loss of consciousness, intravenous line
was inserted and when adequate depth of anesthesia was
reached appropriate LMA was placed and the patient was left
to breath spontaneously. The anesthetic level was delivered in a
concentration that maintained a stable heart rate, blood pres-
sure and respiratory rate (baseline ± 20%). Standard monitor-
ing was done by using ECG, noninvasive blood pressure,
respiratory rate, pulse oximetry and capnography. After the
end of surgery anesthetic gases were discontinued to 0% and re-
placed with O2 100%P4 L/min. LMA was removed when the
patient was awake then the patient transferred to the recovery
room for monitoring of vital signs till discharged to the ward.
2.1. Measurements
Baseline heart rate (HR), respiratory rate, oxygen saturation
(SpO2), and blood pressure (BP) were measured before and
every 10 min after intranasal drug administration for 30 min
until transfer to the operating room (OR). The degree of seda-
tion was assessed every 5 min for 30 min by using a 4 point
sedation scale. Sedation level: Agitated = 4, awake = 3,
Drowsy = 2, Asleep = 1. A sedation score of 3 and above
was considered as unsatisfactory while scores 1 and 2 were
considered to be satisfactory. The response to the child–parent
separation was assessed and graded according to a 4 point
scale at 30 min. Separation score: Patient unafraid, coopera-
tive, asleep = 1, Slight fear or crying, quite with reassur-
ance = 2, Moderate fear, crying not quite with
reassurance = 3, and Crying need for restraint = 4. Duration
of anesthesia (time from start of anesthesia till discontinuation
of all anesthetics) in minutes and duration of the procedure
(bone marrow biopsy and aspirate) in minutes were recorded.
Also, postoperative adverse effects as nausea, vomiting, in-
creased secretion and bradycardia was reported.
2.2. Statistical methods
The statistical software used was SPSS 15.0 for Windows
(SPSS, Chicago, IL). Data were expressed as mean ± SD or
Figure 1 Sedation Score.
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lyzed by Kruskal–Wallis test. When a signiﬁcant result was ob-
tained, the Mann–Whitney U-test was applied for post hoc
pairwise comparisons. Hemodynamic variables including heart
rate (HR), respiratory rate, oxygen saturation (SpO2), and
blood pressure (BP) were analyzed by ANOVA. When a signif-
icant result was obtained, the Tukey test was applied for post
hoc pairwise comparisons. The changes of BP and HR from
baseline among the three groups were tested by Kruskal–
Wallis t-test. p< 0.05 was considered signiﬁcant.
3. Results
Demographic data including age, weight, and sex were compa-
rable in the three groups. Also, there was no statistical differ-
ence in the duration of anesthesia (time from starting
anesthesia till discontinuation of all anesthetics) and duration
of the procedure (bone marrow biopsy and aspirate) between
three groups (Table 1).
Concerning the sedation score, we observed that dexmede-
tomidine group achieved a signiﬁcantly faster sedation score
less than 3 at the point of 10 min than that of midazolam
and ketamine groups (p< 0.05). But we observed that all
groups achieved a comparable sedation score at 15, 20, and
25 min. At 30 min both dexmedetomidine and midazolam
groups had better sedation score than ketamine group (Table 2)
(Fig. 1).
Number and percentage of children achieved child–parents
separation score grade 1 was signiﬁcantly higher in D group
than M and K groups 30(93.75%), 28(87.5%), 22(68%)
respectively (Table 2) (Fig. 1).
Overall, we did not observe any clinically signiﬁcant effects
of any of the studied drugs on SpO2 below 95% during theTable 1 Demographic data of patients included in
Midazolam group
(n= 32)
Age (yr) 4.84 ± 0.44
Weight (kg) 18.33 ± 4.27
Duration of anesthesia (min) 25.21 ± 4.01
Duration of procedure (min) 18.52 ± 1.18
Table 2 Sedation and separation scores (mean ± S
Midazolam
group (N= 32)
Sedation score
Baseline 3.89 ± 0.79
5 min 3.21 ± 0.50
10 min 3.03 ± 0.48
15 min 2.32 ± 0.51*
20 min 2.21 ± 0.70*
25 min 1.92 ± 0.61*
30 min 1.43 ± 0.76**,a
Children achieved child–parents separation score grade I
Number (percentage) 28 (87.5%)
* p< 0.05.
** p< 0.01 (within the same group in comparison to the
a p< 0.05 (between all studied groups).observation period after premedication. There was no signiﬁ-
cant difference in heart rate, systolic blood pressure and respi-
ratory rate between three groups while all these parameters at
all groups were signiﬁcantly decreased at 30 min value when
compared with basal readings (P< 0.05) (Table 3). None of
the children included in the study had signiﬁcant nausea, vom-
iting or bradycardia.
4. Discussion
The preoperative anxiety in children can lead to postoperative
maladaptive behaviors in the form of eating problems, bad
dreams, enuresis, increased fear of doctors and hospital, tem-
per tantrums is well known [12,13]. Hence all pediatric patients
should be premedicated in order to decrease preoperative anx-
iety, allow smooth induction, and prevent postoperative psy-
chological insult and behavioral changes [14,15].
Our study evaluated the efﬁcacy of intranasal midazolam,
ketamine and dexmedetomidine as premedicant in pediatricall groups (mean ± SD).
Ketamine group
(n= 32)
Dexmedetomidine
group (n= 32)
4.93 ± 0.49 5.01 ± 0.40
18.26 ± 4.12 18.95 ± 4.31
24.14 ± 3.73 24.44 ± 3.91
18.41 ± 1.12 19.02 ± 0.97
D).
Ketamine
group (N= 32)
Dexmedetomidine
group (N= 32)
3.91 ± 0.74 3.93 ± 0.88
3.39 ± 0.61 3.00 ± 0.73
3.10 ± 0.50 2.66 ± 0.45*
2.67 ± 0.49* 2.18 ± 0.50*
2.41 ± 0.68* 2.10 ± 0.71*
2.01 ± 0.57* 1.94 ± 0.59*
1.71 ± 0.78** 1.44 ± 0.81**,a
22 (68%) 30a (93.75%)
base line).
Table 3 Oxygen saturation and hemodynamic changes (mean ± SD).
Midazolam
group (N= 32)
Ketamine
group (N= 32)
Dexmedetomidine
group (N= 32)
Oxygen saturation (%) (SpO2)
Baseline 98.4 ± 1.11 98.3 ± 1.13 97.3 ± 1.20
10 min 98.4 ± 1.1 97.3 ± 1.2 97 ± 1.1
20 min 97.5 ± 1.6 98.3 ± 1.4 96.8 ± 1.9
30 min 97.2 ± 1.1 97.6 ± 1.5 97.4 ± 1.1
Systolic blood pressure (SBP) (mmHg)
Baseline 97.5 ± 4.5 97.3 ± 3.6 98.1 ± 2.5
10 min 97.1 ± 4.3 97.4 ± 3.8 97.2 ± 1.3
20 min 94.4 ± 2.2 95.3 ± 3.6 94.2 ± 1.1
30 min 90.2 ± 2.1* 92.7 ± 3.1* 89.1 ± 0.7*
Heart rate (HR) (Beats/min)
Baseline 110.2 ± 3.2 109.3 ± 2.2 110.2 ± 2.1
10 min 107.1 ± 1.9 107.2 ± 2.1 106.1.1 ± 1.1
20 min 100.3 ± 1.9 102.3 ± 3.3 100.3 ± 0.9
30 min 93.1 ± 1.1* 100.3 ± 2.2* 95.1 ± 0.2*0
Respiratory rate (RR) (Rate/min)
Baseline 26.93 ± 4.3 27.25 ± 3.3 27.12 ± 3.2
10 min 26.82 ± 3.1 27.1 ± 3.2 26.3 ± 5.5
20 min 23.3 ± 2.2 24.92 ± 2.2 24.1 ± 3.3
30 min 22.2 ± 3.2* 23.3 ± 3.5* 22.8 ± 2.3*
* p< 0.05 (within the same group in comparison to the base line).
134 M.G. Mostafa, K.M. Morsypatient; we did not include placebo group as these drugs when
compared with placebo the effectiveness was found to be supe-
rior to placebo in previous studies [16–20]. Many sedative
analgesic agents and routes of delivery for facilitation of pain-
ful procedures have been studied, with varying degrees of pa-
tient acceptance, efﬁcacy and safety [16]. The intranasal
route may be irritating to nasal mucosa and drugs adminis-
tered through it may traverse directly into the central nervous
system through the cribriform plate by traveling along the
olfactory nerves [17]. In our study, we selected children
between 2 and 8 years where this age is most susceptible to
the separation anxiety and their understanding is limited.
The intranasal administration of midazolam 0.2 mg/kg,
ketamine 5 mg/kg and dexmedetomidine 1 lg/kg produced
effective and signiﬁcant sedation which was seen at 10 min in
dexmedetomidine group and at 15 min in midazolam and
ketamine groups and this change was maintained in all groups
at 20 min and at the time of induction of anesthesia and these
results were comparable with the results of Naill et al. [18].
Malionovsky et al. [19] found that intranasal midazolam
0.2 mg/kg had produced more rapid sedation than when
administered through other routes. Also, Lejus et al. [20] re-
ported that intranasal midazolam 0.2 mg/kg is an effective
and rapid route of premedication yet one that is poorly ac-
cepted by patients. Shashikiran et al. [21] found that on 40 chil-
dren requiring conscious sedation, intranasal and
intramuscular midazolam produced effective and comparable
sedation with equal efﬁcacy and safety proﬁles. But Lam
et al. [22] proved that intramuscular midazolam produced bet-
ter sedation and less movement at venipuncture than when
used intranasally.
The variation in the onset of sedation in our results may be
due to the site and mechanism of action of these drugs, as the
site of action of midazolam and dexmedetomidine in thecentral nervous system in locus coeruleus where it induce elec-
troencephalogram activity similar to natural sleep [23] but ket-
amine is a derivative of phencyclidine that creates trance like
dissociative state characterized by sedation, amnesia, analge-
sia, and catalepsy. There are several reports about intranasal
administration of ketamine (5–6 mg/kg) with good efﬁcacy
and no adverse effects for premedication and sedation in chil-
dren [24,25].
Garcia-Velascop et al. [24] compared intranasal midazolam
(0.25 mg/kg) and ketamine (5 mg/kg) in pediatric patients
found that the nasal route of administration of the drugs is
well accepted in both groups and midazolam and ketamine
are equally effective as sedative premedication.
Wilton et al. [4] concluded that intranasal midazolam
0.2 mg/kg produced sedation comparable with a dose of
0.3 mg/kg and both were better than placebo. Ashu et al.
[26] reported that intranasal midazolam 0.2 mg/kg produced
a more rapid onset of sedation (average 4.8 min) and time
of maximal sedation was only 12.7 min and this is not agree-
ment of our study and this could be due age range in his
study started from 6 month up to 6 years. Vivian et al. [27]
reported that 75% of the children attained a satisfactory le-
vel of sedation after 1 lg/kg intranasal dexmedetomidine.
Moreover, 70.8% of these sedated patients allowed IV or in-
haled induction without showing signs of distress or
awakening.
Our study showed that there was statistically signiﬁcant
change in heart rate, respiratory rate and systolic blood pres-
sure in each group after 30 min and this may be due to in-
creased level of sedation which is in agreement with
Remadevi et al. [28]. Munro et al. [29] reported that the reduc-
tion of blood pressure and heart rate were <20% of baseline
in children who were sedated with initial dose of 1 lg/kg IV
dexmedetomidine but Vivian et al. [27] shown that 0.5 and
Premedication with intranasal dexmedetomidine, midazolam and ketamine for children 1351 lg/kg intranasal dexmedetomidine reduces heart rate and
blood pressure in healthy children during the ﬁrst hour after
drug administration.
Talke et al. [30] demonstrated that intranasal dexmedetom-
idine 1 lg/kg reduced HR and SBP during the preoperative
sedation period and this may be due to dexmedetomidine is
known to decrease sympathetic outﬂow and circulating cate-
cholamine levels. This study support the data presented by
Audenaert and colleges [31] who found that intranasal keta-
mine 5 mg/kg did not produce signiﬁcant cardiovascular and
respiratory side effects and this is agreement with our study.
In conclusion we found that midazolam, ketamine and dex-
medetomidine produced adequate sedation with little side ef-
fects. So, we prefer to use midazolam due its efﬁcacy and
safety as well as availability and its low price in comparison
to ketamine and dexmedetomidine.
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